Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Delayed Quote USD

Quest Diagnostics Incorporated (DGX)

Compare
167.33
+1.33
+(0.80%)
At close: March 28 at 4:00:02 PM EDT
166.00
-1.33
(-0.79%)
After hours: March 28 at 6:31:01 PM EDT
Loading Chart for DGX
  • Previous Close 166.00
  • Open 166.12
  • Bid 152.54 x 800
  • Ask 181.22 x 800
  • Day's Range 165.10 - 167.79
  • 52 Week Range 125.42 - 178.87
  • Volume 1,140,821
  • Avg. Volume 1,104,983
  • Market Cap (intraday) 18.57B
  • Beta (5Y Monthly) 0.92
  • PE Ratio (TTM) 21.73
  • EPS (TTM) 7.70
  • Earnings Date Apr 21, 2025 - Apr 25, 2025
  • Forward Dividend & Yield 3.20 (1.91%)
  • Ex-Dividend Date Apr 7, 2025
  • 1y Target Est 177.10

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

www.questdiagnostics.com

45,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: DGX

View More

Performance Overview: DGX

Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

DGX
11.46%
S&P 500 (^GSPC)
5.11%

1-Year Return

DGX
28.36%
S&P 500 (^GSPC)
6.22%

3-Year Return

DGX
22.83%
S&P 500 (^GSPC)
21.97%

5-Year Return

DGX
122.96%
S&P 500 (^GSPC)
119.59%

Compare To: DGX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DGX

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    18.57B

  • Enterprise Value

    25.11B

  • Trailing P/E

    21.76

  • Forward P/E

    17.21

  • PEG Ratio (5yr expected)

    1.51

  • Price/Sales (ttm)

    1.92

  • Price/Book (mrq)

    2.74

  • Enterprise Value/Revenue

    2.54

  • Enterprise Value/EBITDA

    13.26

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.82%

  • Return on Assets (ttm)

    5.84%

  • Return on Equity (ttm)

    13.83%

  • Revenue (ttm)

    9.87B

  • Net Income Avi to Common (ttm)

    866M

  • Diluted EPS (ttm)

    7.70

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    549M

  • Total Debt/Equity (mrq)

    103.26%

  • Levered Free Cash Flow (ttm)

    741M

Research Analysis: DGX

View More

Company Insights: DGX

Research Reports: DGX

View More

People Also Watch